Aequus Pharmaceuticals (CVE:AQS) Stock Passes Below 50 Day Moving Average – Here’s Why

by · The Markets Daily

Aequus Pharmaceuticals Inc. (CVE:AQS – Get Free Report) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$0.01 and traded as low as C$0.01. Aequus Pharmaceuticals shares last traded at C$0.01, with a volume of 100,000 shares traded.

Aequus Pharmaceuticals Trading Down 37.5%

The business’s 50-day moving average price is C$0.01 and its 200 day moving average price is C$0.01. The company has a market cap of C$663,150.00, a P/E ratio of -0.50 and a beta of -0.02. The company has a debt-to-equity ratio of 138.88, a quick ratio of 0.46 and a current ratio of 0.07.

About Aequus Pharmaceuticals

(Get Free Report)

Aequus Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.

Further Reading